Screener
UroGen Pharma URGN Business Segments — Other Selling General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:OtherSellingGeneralAndAdministrativeExpense.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's business segments — other selling general and administrative expense?
- UroGen Pharma (URGN) reported business segments — other selling general and administrative expense of $2.36M in Q2 2026.
- What does business segments — other selling general and administrative expense mean?
- This metric aggregates miscellaneous selling, general, and administrative costs that are not categorized under specific line items like marketing or professional fees. It captures the residual operational overhead required to run the corporate entity and support administrative functions. Monitoring this helps identify trends in general corporate spending and administrative efficiency.
Ask your AI about UroGen Pharma's business segments — other selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude